OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GILD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Gilead Sciences (GILD) Earnings Date & Reports

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GILD is expected to report earnings to rise 7.96% to $2.17 per share on October 23

Gilead Sciences GILD Stock Earnings Reports

Q3'25

Est.

$2.17

Q2'25

Beat

by $0.05

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.19

Q3'24

Beat

by $0.51

The last earnings report on August 07 showed earnings per share of $2.01, beating the estimate of $1.96. With 576.58K shares outstanding, the current market capitalization sits at 148.16B.

View a ticker or compare two or three

Compare

GILD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GILD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GILD showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Biotechnology

Address

333 Lakeside Drive

Phone

+1 650 574-3000

Employees

18000

Web

https://www.gilead.com